The Waldorf agenda handed insurers, AI firms, and companies with business before HHS a place beside the officials who regulate them.
MAHA’s anti-corporate health revolt landed at the Waldorf Astoria and turned into a corporate access pageant.
Politico reported that Walmart, OpenAI, and Anthropic sponsored the summit and could attend a private dinner with speakers that included HHS officials. Its official agenda placed UnitedHealth, Elevance, and the insurance lobby AHIP on an “Affordability First” panel. It put OpenAI and Anthropic representatives on health-AI panels and GRAIL’s CEO on cancer detection.
Calley Means joined FDA Acting Commissioner Kyle Diamantas and EPA Administrator Lee Zeldin on a regulation panel.
William Makis noted the program listed no session on ivermectin, mebendazole, fenbendazole, or other repurposed drugs.
In June, Jack Kruse warned MAHA had become “HAHA” and called Calley and Casey Means the “facade” of a corporate power move. The sponsor list and stage now echo that warning.